Adherence in Acute Coronary Syndrome

Published Online: Monday, March 25, 2013
Follow Pharmacy_Times:
In this video, from AJMCtv, Jeffrey Berger, MD, assistant professor at NYU Langone Medical Center, discusses how research can help increase adherence to therapies among acute coronary syndrome (ACS) patients.

Related Articles
In my limited experience at retail pharmacies, I rarely see patients being counseled.
Could changes in the physical attributes of generic drugs affect patient adherence?
If the results of the DAPT trial encourage health care professionals to prescribe dual antiplatelet therapy beyond 12 months, then pharmacists may have a few more points to discuss with patients.
As the quality measurement environment changes, pharmacists may shift their focus to new areas.
Latest Issues
$auto_registration$